Israel says signed MOU with NRX Pharmaceuticals for COVID vaccine trials
- Country:
- Israel
Israel has signed a memorandum of understanding with NRX Pharmeceuticals to complete trials and commercialize the Israeli-developed COVID-19 vaccine BriLife, Israel's Defense Ministry said on Monday.
The vaccine was developed by the Israel Institute for Biological Research, which is overseen by the Defense Ministry.
ALSO READ
-
Iran’s Civilians Trapped Between State Repression and Deadly Strikes, UN Warns
-
UN Experts See UK Settlement Curbs as Turning Point, Urge Action Over Occupation
-
US Approves Potential Sale of F-35 Jets to Saudi Arabia, Shifting Middle Eastern Power Dynamics
-
UN Assembly Allows Abbas Virtual Address Amid US Visa Row
Google News